1. Mitogenic properties of a bispecific single-chain Fv-Ig fusion generated from CD2-specific mAb to distinct epitopes.
- Author
-
Connelly, RJ, Hayden, MS, Scholler, JK, Tsu, TT, Dupont, B, Ledbetter, JA, and Kanner, SB
- Abstract
The combination of anti-CD2 mAb 9.6 and 9-1, specific for distinct epitopes, induces proliferation of resting human T cells. The mitogenic activity of this mAb mixture depends upon accessory cells and the 9-1 mAb Fc domain. To further study the functional properties of these mAb, their variable regions were cloned and expressed as monospecific single-chain Fv (scFv) proteins fused to the human IgG1 Fc domain (scFvlg). A novel bispecific scFvlg was constructed by cloning the two monospecific scFv binding sites in tandem, with the 9.6 scFv placed N-terminal to the 9-1 scFvlg. Monospecific scFvlg binding to CD2 was comparable to that of the corresponding parental mAb, while the bispecific scFvlg exhibited binding activity similar to that of the 9-1 scFvlg. The combination of 9.6 scFvlg and 9-1 mAb was mitogenic, whereas mixtures including the 9-1 scFvlg were non-stimulatory, confirming the unique properties of the 9-1 IgG3 Fc. Without the IgG3 tail, the bispecific 9.6/9-1 scFvlg was directly mitogenic and was a more potent mitogen than the mAb mixture but was accessory cell dependent. Unlike the combination of mAb, the bispecific reagent did not directly mobilize calcium in T cells. In comparison to the mAb mixture, bispecific 9.6-9-1 scFvlg-mediated stimulation of a mixed lymphocyte reaction was significantly more resistant to inhibition of the CD28 co-stimulatory pathway by the inhibitor CTLA-4-Ig. These results show that expression of the 9.6 and 9-1 binding sites together on a bispecific scFvlg increased the mitogenic properties of the mAb and altered the degree of accessory cell signals required for T cell activation. [ABSTRACT FROM PUBLISHER]
- Published
- 1998
- Full Text
- View/download PDF